Drug · DIN 02568373
THYCONVI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 25, 2026; first marketed May 25, 2026.
- Drug Identification Number (DIN)
- 02568373
- Company (DIN owner)
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Oral
- Therapeutic class (ATC)
- Levothyroxine sodium H03AA01
- Class
- Human
- Record last updated
- September 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVOTHYROXINE SODIUM | 20 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 15, 2026: NOC 37564New Drug Submission (NDS)